XRAY
DENTSPLY SIRONA Inc. Healthcare - Dental Products Investor Relations →
DENTSPLY SIRONA Inc. (XRAY) closed at $13.37 as of 2026-07-31, trading 41.2% below its 200-week moving average of $22.73. This places XRAY in the extreme value zone. The stock moved further from the line this week, up from -43.3% last week. The 14-week RSI sits at 59, indicating neutral momentum.
Trading volume is running at 0.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.03 ratio) is neutral — neither side is clearly dominating.
Over the past 1985 weeks of data, XRAY has crossed below its 200-week moving average 23 times. On average, these episodes lasted 22 weeks. Historically, investors who bought XRAY at the start of these episodes saw an average one-year return of +18.2%.
With a market cap of $2.7 billion, XRAY is a mid-cap stock. The company generates a free cash flow yield of 4.8%. Return on equity stands at -37.7%. The stock trades at 2.0x book value.
The company has been aggressively buying back shares, reducing its share count by 7.3% over the past three years.
Over the past 33.6 years, a hypothetical investment of $100 in XRAY would have grown to $217, compared to $3098 for the S&P 500. XRAY has returned 2.3% annualized vs 10.8% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 11 open-market purchases totaling $1,740,997. Multiple insiders purchased within a 30-day window — a cluster buy pattern that historically signals management confidence in the company's prospects. Notably, these purchases occurred while XRAY is trading below its 200-week moving average — insiders are buying when the market is most pessimistic.
Free cash flow has been declining at a -34.4% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: XRAY vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After XRAY Crosses Below the Line?
Across 20 historical episodes, buying XRAY when it crossed below its 200-week moving average produced an average return of +6.5% after 12 months (median +9.0%), compared to +16.5% for the S&P 500 over the same periods. 60% of those episodes were profitable after one year. After 24 months, the average return was +25.2% vs +27.9% for the index.
Each line shows $100 invested at the moment XRAY crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Bean Score Experimental
The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. Between earnings dates, FCF is constant — so the score is purely a function of stock price. The levels below show at what prices XRAY would reach each dislocation threshold.
Dislocation Price Levels
Prices where XRAY's Bean Score would hit each σ threshold. Valid until next earnings report (date TBD — last report: 2026-03-31).
| Level | σ | Price | Signal |
|---|---|---|---|
| Deep Value | +2σ | $9.67 | Unusually cheap — potential buy zone |
| Value | +1σ | $10.63 | Cheap vs. own history |
| Fair Value | +0σ | $11.81 | Historical mean behavior |
| Expensive | -1σ | $13.29 | Expensive vs. own history |
| Deep Expensive | -2σ | $15.18 | Unusually expensive — potential trim zone |
Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end
Signal Accuracy Collecting Data
The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"
Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.
Dislocation Scores Experimental
Each score measures deviation from XRAY's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.
Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.
Historical Touches
XRAY has crossed below its 200-week MA 23 times with an average 1-year return of +18.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Aug 1988 | Aug 1988 | 1 | 1.5% | +31.2% | +2548.1% |
| Oct 1988 | Jul 1989 | 37 | 16.7% | +38.7% | +2633.5% |
| Oct 1990 | Nov 1990 | 1 | 2.2% | +197.3% | +2190.3% |
| Dec 1994 | Dec 1994 | 1 | 0.7% | +30.1% | +271.5% |
| Sep 1998 | Oct 1998 | 6 | 8.3% | +14.2% | +136.3% |
| Mar 1999 | Apr 1999 | 3 | 4.2% | +23.8% | +120.8% |
| Aug 1999 | Aug 1999 | 1 | 0.1% | +41.9% | +108.5% |
| Sep 1999 | Jan 2000 | 20 | 13.4% | +51.5% | +120.9% |
| Oct 2008 | Aug 2009 | 45 | 31.6% | +18.6% | -46.6% |
| Oct 2009 | Nov 2009 | 1 | 1.1% | -4.2% | -51.4% |
| Nov 2009 | Nov 2009 | 2 | 1.7% | -5.0% | -51.2% |
| Jan 2010 | Mar 2010 | 5 | 3.4% | +7.3% | -52.3% |
| May 2010 | Dec 2010 | 32 | 15.0% | +14.0% | -52.7% |
| Aug 2011 | Aug 2011 | 2 | 6.7% | +14.8% | -53.1% |
| Sep 2011 | Oct 2011 | 6 | 8.9% | +15.7% | -51.1% |
| Nov 2011 | Nov 2011 | 1 | 1.5% | +20.5% | -51.7% |
| Aug 2017 | Aug 2017 | 1 | 2.9% | -26.3% | -71.0% |
| Mar 2018 | Apr 2019 | 59 | 38.3% | -12.1% | -72.8% |
| May 2019 | Jun 2019 | 3 | 1.3% | -30.2% | -72.2% |
| Jul 2019 | Oct 2019 | 13 | 6.9% | -14.8% | -71.3% |
| Feb 2020 | Nov 2020 | 39 | 38.8% | +8.8% | -69.4% |
| Nov 2021 | Nov 2021 | 1 | 0.6% | -36.0% | -70.2% |
| Mar 2022 | Ongoing | 230+ | 63.3% | Ongoing | -69.6% |
| Average | 22 | — | +18.2% | — |
Frequently Asked Questions
Is XRAY below its 200-week moving average?
Yes. As of 2026-07-31, DENTSPLY SIRONA Inc. (XRAY) is trading 41.2% below its 200-week moving average of $22.73. The current price is $13.37.
What is XRAY's 200-week moving average price?
DENTSPLY SIRONA Inc.'s 200-week moving average is $22.73 as of 2026-07-31. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when XRAY drops below its 200-week moving average?
XRAY has crossed below its 200-week moving average 23 times in our data. On average, buying at that moment produced a one-year return of +18.2%. These dips have historically been decent entry points. These episodes lasted 22 weeks on average.
Is XRAY a good value right now?
Here's what our data says about XRAY as of 2026-07-31: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 59. Free cash flow yield is 4.8%. Return on equity is -37.7%. Price-to-book is 2.0x. This is not a buy or sell recommendation — always do your own research.
How does XRAY compare to the S&P 500?
Over the past 33.6 years, $100 invested in XRAY would have grown to $217, compared to $3098 for the S&P 500. That's 2.3% annualized vs 10.8% for the index. XRAY has underperformed the broader market over this period.
Does XRAY pay a dividend?
Yes. DENTSPLY SIRONA Inc. currently pays a dividend yield of 504.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-07-31